Details for New Drug Application (NDA): 019621
✉ Email this page to a colleague
The generic ingredient in VENTOLIN is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Summary for 019621
Tradename: | VENTOLIN |
Applicant: | Glaxosmithkline |
Ingredient: | albuterol sulfate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | EQ 2MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 10, 1987 | TE: | RLD: | No |
Expired US Patents for NDA 019621
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | VENTOLIN | albuterol sulfate | SYRUP;ORAL | 019621-001 | Jun 10, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | VENTOLIN | albuterol sulfate | SYRUP;ORAL | 019621-001 | Jun 10, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | VENTOLIN | albuterol sulfate | SYRUP;ORAL | 019621-001 | Jun 10, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription